MENU
+Compare
TMDX
Stock ticker: NASDAQ
AS OF
Sep 26, 11:57 AM (EDT)
Price
$113.60
Change
-$0.30 (-0.26%)
Capitalization
3.88B

TMDX TransMedics Group Forecast, Technical & Fundamental Analysis

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TMDX with price predictions
Sep 24, 2025

TMDX in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 04, 2025

TMDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 27 cases where TMDX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TMDX's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 16, 2025. You may want to consider a long position or call options on TMDX as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TMDX just turned positive on September 12, 2025. Looking at past instances where TMDX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

TMDX moved above its 50-day moving average on September 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TMDX crossed bullishly above the 50-day moving average on September 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where TMDX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TMDX entered a downward trend on September 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TMDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.210) is normal, around the industry mean (60.267). P/E Ratio (57.236) is within average values for comparable stocks, (37.392). TMDX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.697). TMDX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (8.110) is also within normal values, averaging (78.998).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TMDX is expected to report earnings to fall 60.53% to 36 cents per share on November 11

TransMedics Group TMDX Stock Earnings Reports
Q3'25
Est.
$0.36
Q2'25
Beat
by $0.47
Q1'25
Beat
by $0.44
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.17
The last earnings report on July 30 showed earnings per share of 92 cents, beating the estimate of 44 cents. With 99.79K shares outstanding, the current market capitalization sits at 3.88B.
A.I. Advisor
published General Information

General Information

a developer of a proprietary system for preserving human organs for transplant

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
200 Minuteman Road
Phone
+1 978 552-0900
Employees
584
Web
https://www.transmedics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGNCX39.160.20
+0.51%
Victory Global Energy Transition C
FBGRX255.94N/A
N/A
Fidelity Blue Chip Growth
JACDX10.58-0.05
-0.47%
JHancock Global Environmental Opps R6
PHEFX13.44-0.07
-0.52%
T. Rowe Price Hedged Equity
APDSX36.71-0.44
-1.18%
Artisan Small Cap Advisor

TMDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with AXGN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then AXGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMDX
1D Price
Change %
TMDX100%
-3.01%
AXGN - TMDX
39%
Loosely correlated
-2.76%
RDNT - TMDX
37%
Loosely correlated
-0.53%
SMTI - TMDX
33%
Loosely correlated
-3.67%
NNOX - TMDX
32%
Poorly correlated
-4.67%
NVST - TMDX
30%
Poorly correlated
-2.73%
More

Groups containing TMDX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMDX
1D Price
Change %
TMDX100%
-3.01%
Medical/Nursing Services
industry (226 stocks)
35%
Loosely correlated
-1.80%
Health Services
industry (438 stocks)
22%
Poorly correlated
-0.07%